Evidence map›Paper›PMID 40467918›Full record

ArticleScientific reports2025

Precise detection of differential RNA editing sites across varied biological conditions using the CADRES pipeline.

Jun Sun, Chi Zhang, Xiuling Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jun Sun *Shanghai Institute of Biological Products, 350 Anshun Road, Shanghai, 200051, China.
Chi Zhang *Shanghai Institute of Biological Products, 350 Anshun Road, Shanghai, 200051, China. chi.zhang1@aliyun.com.
Xiuling LiShanghai Institute of Biological Products, 350 Anshun Road, Shanghai, 200051, China. lixiuling@sinopharm.com.

Funding

Science and Technology Commission of Shanghai Municipality 23S11901100Shanghai Pujiang Programme 22PJD104
6 · The paper itself

Abstract

RNA editing is an important post-transcriptional modification for gene regulation and protein diversity. Detecting these modifications, especially Differential Variants on RNA (DVRs), presents significant challenges due to interference from sequencing errors and genetic variants. Currently, despite millions of A>I editing sites having been identified, a significant gap remains in identifying C>U RNA editing sites, mediated by cytidine deaminases, which target both DNA and RNA. To improve the detection and analysis of C>U RNA editing sites, we developed the Calibrated Differential RNA Editing Scanner (CADRES), an analytical pipeline that combines sophisticated DNA/RNA variant calling with detailed statistical analysis on depth of RNA editing. This study validates CADRES through rigorous in silico and experimental datasets using inducible cell models of the APOBEC3B (A3B) deaminase. CADRES demonstrates improved specificity and accuracy over existing methodologies, effectively identifying A3B-mediated C>U edits while filtering against sequencing artefacts and A3B-mediated DNA mutations. Our findings demonstrate that CADRES provides a reliable tool for the precise identification of C>U RNA editing sites, which will help understand the molecular mechanisms underlying cytidine deamination on RNA and its functions.

Indexed as

RNA EditingCytidine DeaminaseHumansMinor Histocompatibility AntigensRNAAPOBEC3B protein, humanCytidine DeaminaseMinor Histocompatibility AntigensRNAAPOBEC deaminaseBioinformaticsDifferential Variants on RNA (DVRs)Next-generation sequencingRNA editingVariant calling

Identifiers

PMID40467918
PMCPMC12137548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.